Na Young Kim

6PUBLICATIONS
11CO-AUTHORS
Molecular targetsMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 04, 2026
Norisoboldine suppresses epithelial-mesenchymal transition in colorectal cancer by simultaneously inhibiting the CXCR4/CXCR7 chemokine receptors and the JAK/STAT3 signaling pathway.

|Aug 06, 2025
Cannabidiol Suppresses EMT in Pancreatic Cancer via Inhibition of MALAT1 lncRNA and PI3K/Akt/mTOR Signaling Pathway.

Na Young Kim, Young Yun Jung, Jae-Young Um

|Feb 15, 2024
Cannabidiol activates MAPK pathway to induce apoptosis, paraptosis, and autophagy in colorectal cancer cells.

Na Young Kim, Chakrabhavi Dhananjaya Mohan, Gautam Sethi

|Sep 28, 2023
Euphorbiasteroid Induces Apoptosis as Well as Autophagy through Modulating SHP-1/STAT3 Pathway in Hepatocellular Carcinoma Cells.

Na Young Kim, Gautam Sethi, Jae-Young Um

|Apr 28, 2023
Discovery of Pyrimidine- and Coumarin-Linked Hybrid Molecules as Inducers of JNK Phosphorylation through ROS Generation in Breast Cancer Cells.

Na Young Kim, Divakar Vishwanath, Zhang Xi

|Jun 24, 2022
Euphorbiasteroid Abrogates EGFR and Wnt/β-Catenin Signaling in Non-Small-Cell Lung Cancer Cells to Impart Anticancer Activity.

Na Young Kim, Chakrabhavi Dhananjaya Mohan, Arunachalam Chinnathambi

Pageof 1

Frequent Collaborators

6 joint publications

Kwang Seok Ahn

1 joint publications

Arunachalam Chinnathambi

1 joint publications

Divakar Vishwanath

1 joint publications

Zhang Xi